Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Preferred Stock	Additional Paid- in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balances (in Shares) at Dec. 31, 2020	25,085,534
Balances at Dec. 31, 2020	$ 250,855		$ 219,129,045	$ 2,547,182	$ (200,735,827)	$ 21,191,255
Offering of common stock and warrants, net of issuance costs (in Shares)	8,333,333
Offering of common stock and warrants, net of issuance costs	$ 83,334		23,390,628			23,473,962
Inducement expense related to warrant reprice			7,755,541			7,755,541
Common stock warrant exercises, net of issuance costs	$ 48,476		9,045,696			9,094,172
Common stock warrant exercises, net of issuance costs (in Shares)	4,847,615
Proceeds from issuance of common stock warrants			255,751			255,751
Stock compensation expense			189,670			189,670
Foreign currency translation				(1,078,479)		(1,078,479)
Net loss					(14,850,591)	(14,850,591)
Balances at Mar. 31, 2021	$ 382,665		259,766,331	1,468,703	(215,586,418)	46,031,281
Balances (in Shares) at Mar. 31, 2021	38,266,482
Balances (in Shares) at Dec. 31, 2020	25,085,534
Balances at Dec. 31, 2020	$ 250,855		219,129,045	2,547,182	(200,735,827)	21,191,255
Inducement expense related to warrant reprice						7,755,541
Net loss						(27,993,848)
Balances at Sep. 30, 2021	$ 382,703		260,244,997	1,400,827	(228,729,675)	33,298,852
Balances (in Shares) at Sep. 30, 2021	38,270,250
Balances (in Shares) at Mar. 31, 2021	38,266,482
Balances at Mar. 31, 2021	$ 382,665		259,766,331	1,468,703	(215,586,418)	46,031,281
Issuance of RSUs	$ 38		(38)
Issuance of RSUs (in Shares)	3,768
Stock compensation expense			261,548			261,548
Foreign currency translation				529,651		529,651
Net loss					(7,086,561)	(7,086,561)
Balances at Jun. 30, 2021	$ 382,703		260,027,841	1,998,354	(222,672,979)	39,735,919
Balances (in Shares) at Jun. 30, 2021	38,270,250
Stock compensation expense			217,156			217,156
Foreign currency translation				(597,527)		(597,527)
Net loss					(6,056,696)	(6,056,696)
Balances at Sep. 30, 2021	$ 382,703		260,244,997	1,400,827	(228,729,675)	33,298,852
Balances (in Shares) at Sep. 30, 2021	38,270,250
Balances (in Shares) at Dec. 31, 2021	46,450,250
Balances at Dec. 31, 2021	$ 464,503		275,708,490	585,626	(235,541,539)	41,217,080
Issuance of RSUs	$ 1,075		(1,075)
Issuance of RSUs (in Shares)	107,500
Stock compensation expense			241,619			241,619
Foreign currency translation				(483,849)		(483,849)
Net loss					(6,803,716)	(6,803,716)
Balances at Mar. 31, 2022	$ 465,578		275,949,034	101,777	(242,345,255)	34,171,134
Balances (in Shares) at Mar. 31, 2022	46,557,750
Balances (in Shares) at Dec. 31, 2021	46,450,250
Balances at Dec. 31, 2021	$ 464,503		275,708,490	585,626	(235,541,539)	41,217,080
Inducement expense related to warrant reprice
Net loss						(26,748,113)
Balances at Sep. 30, 2022	$ 483,386		277,406,700	(1,662,123)	(262,289,652)	13,938,311
Balances (in Shares) at Sep. 30, 2022	48,338,500
Balances (in Shares) at Mar. 31, 2022	46,557,750
Balances at Mar. 31, 2022	$ 465,578		275,949,034	101,777	(242,345,255)	34,171,134
Issuance of RSUs	$ 659		(659)
Issuance of RSUs (in Shares)	65,868
Stock compensation expense			257,403			257,403
Foreign currency translation				(1,227,142)		(1,227,142)
Net loss					(5,840,415)	(5,840,415)
Balances at Jun. 30, 2022	$ 466,237		276,205,778	(1,125,365)	(248,185,670)	27,360,980
Balances (in Shares) at Jun. 30, 2022	46,623,618
Stock compensation expense			228,367			228,367
At the market offering, net of offering costs	$ 17,149		972,555			989,704
At the market offering, net of offering costs (in Shares)	1,714,882
Foreign currency translation				(536,758)		(536,758)
Net loss					(14,103,982)	(14,103,982)
Balances at Sep. 30, 2022	$ 483,386		$ 277,406,700	$ (1,662,123)	$ (262,289,652)	$ 13,938,311
Balances (in Shares) at Sep. 30, 2022	48,338,500